Home :
Agenda
Agenda
Investor Breakfasts - With BioAlliance Pharma Management Team - By invitation only (More information at contact@bioalliancepharma.com)
25 January 2012, From 8:30 to 10:00 am - Company's Headoffice, 49, bd du Général Martial Valin, 75015 Paris
25 January 2012, From 8:30 to 10:00 am - Company's Headoffice, 49, bd du Général Martial Valin, 75015 Paris
17th Annual International Partnering Conference BIO-EUROPE® 2011
31 October 2011, November 2, 2011 – Düsseldorf, Germany
31 October 2011, November 2, 2011 – Düsseldorf, Germany
19th Annual BioPartnering Europe™
10 October 2011, 9-11 October, 2011 – London, United-Kingdom
10 October 2011, 9-11 October, 2011 – London, United-Kingdom
69th Annual Meeting of the AFEF (French Association for the Study of the Liver) - Poster: A Randomized Phase II Trial of Doxorubicine Transdrug™ (Livatag®) Demonstrates Significant Overall Survival Increase in Inoperable Hepatocellular Carcinoma (HCC) Patients
28 September 2011, 1er octobre - Paris
28 September 2011, 1er octobre - Paris
SFAF Analyst Meeting: Presentation of 2011 half-year consolidated results
22 September 2011, September 22, 2011 – Conference call in English at 11:30 am
22 September 2011, September 22, 2011 – Conference call in English at 11:30 am
Midcap Event
22 September 2011, 22-23 September, 2011 – Palais Brongniart, Paris
22 September 2011, 22-23 September, 2011 – Palais Brongniart, Paris
International Liver Cancer Association (ILCA) Fifth Annual Conference - Oral presentation: A Randomized Phase II Trial of Doxorubicin-Transdrug™ (Livatag®) Demonstrates Significant Overall Survival Increase in Inoperable Hepatocellular Carcinoma (HCC) Patients
02 September 2011, 2-4 September, 2011 – Hong Kong
02 September 2011, 2-4 September, 2011 – Hong Kong
Shareholders' Meeting
29 June 2011, Company's Head Office, Paris - France
29 June 2011, Company's Head Office, Paris - France
BIO International Convention 2011
27 June 2011, Washington, US - June 27-29, 2011
27 June 2011, Washington, US - June 27-29, 2011
BioEquity Europe
23 May 2011, May 23 & 24, 2011 - Paris, France
23 May 2011, May 23 & 24, 2011 - Paris, France
Smallcap Event
26 April 2011, April 26 & 27, 2011 - Paris, France
26 April 2011, April 26 & 27, 2011 - Paris, France
Midcap Event
31 March 2011, March 31 & April 1st, 2011 - Brussels, Belgium
31 March 2011, March 31 & April 1st, 2011 - Brussels, Belgium
BIO-Europe Spring 2011
14 March 2011, March 14 & 15, 2011 - Milan, Italy
14 March 2011, March 14 & 15, 2011 - Milan, Italy
SFAF Analyst Meeting: Presentation of the consolidated accounts for 2010
04 March 2011, Company's Head Office, Paris, France
04 March 2011, Company's Head Office, Paris, France
Electrochemotherapy 1st International Users's Meeting - Oral presentation: "Intratumoral electrogenetransfer of plasmid Amep-2 in patients with advanced or metastatic melanoma"
20 November 2010, November 19-20, 2010, Bologna (Italy)
20 November 2010, November 19-20, 2010, Bologna (Italy)
BIO-Europe 2010
15 November 2010, November 15-17, 2010 - Munich, Germany
15 November 2010, November 15-17, 2010 - Munich, Germany
FIP (International Pharmaceutical Federation) in association with AAPS (American Association of Pharmaceutical Scientists) Annual World Meeting - Poster: “Pharmacokinetic and safety of acyclovir Lauriad®, an innovative local drug delivery system for treatment of herpes labialis”
15 November 2010, November 14-18, 2010, New Orleans, Louisiana,USA
15 November 2010, November 14-18, 2010, New Orleans, Louisiana,USA
18th ESGCT (European Society of Gene & Cell Therapy) Congress - Oral presentation: "Development of Amep in melanoma: plasmid Amep, from bench to bedside"
25 October 2010, October 22-25, 2010, Milan (Italy)
25 October 2010, October 22-25, 2010, Milan (Italy)
BioPartnering Europe 2010
10 October 2010, London, UK - October 10-12, 2010
10 October 2010, London, UK - October 10-12, 2010
Midcap Event
20 September 2010, Paris, France, 20 - 21 September 2010
20 September 2010, Paris, France, 20 - 21 September 2010
Presentation of 2010 half-year consolidated results
26 August 2010, Conference call in English at 11.30 am
26 August 2010, Conference call in English at 11.30 am
BioEquity Europe 2010
19 May 2010, Zurich, Switzerland, May 19-20,2010
19 May 2010, Zurich, Switzerland, May 19-20,2010
London European Midcap Event
11 May 2010, London, UK, May 11-12, 2010
11 May 2010, London, UK, May 11-12, 2010
BIO International Convention 2010
03 May 2010, Chicago, Illinois USA - May 3-6, 2010
03 May 2010, Chicago, Illinois USA - May 3-6, 2010
Annual General Meeting
22 April 2010, Company's head office, Paris, France
22 April 2010, Company's head office, Paris, France
Smallcap Event
12 April 2010, Paris, France, 12 - 13 April 2010
12 April 2010, Paris, France, 12 - 13 April 2010
Presentation of the consolidated results for 2009
04 March 2010, Company Head Office, Paris, France
04 March 2010, Company Head Office, Paris, France
ASHP (American Society of Health-System Pharmacists) 2009 Midyear Clinical Meeting - Posters: " Evaluation of miconazole mucoadhesive buccal tablet: A novel, once daily, antifungal regimen for the treatment of oropharyngeal candidiasis"; "Efficacy of miconazole mucoadhesive buccal tablets compared to clotrimazole troches for the treatment of oropharyngeal candidiasis: SMiLES trial"
06 December 2009, Las Vegas, US - 6-10 December, 2009
06 December 2009, Las Vegas, US - 6-10 December, 2009
17th ESGCT (European Society of Gene & Cell Therapy) Annual Congress - Oral presentation: "Plasmid-AMEP: an efficient antiangiogenic and antitumor gene medicinal product for metastatic melanoma treatment"; Poster: "Muscle electrotransfer of Plasmid AMEP, a gene product for melanoma treatment, is safe and well tolerated in mice"
21 November 2009, Hannover, Germany - 21-25 November, 2009
21 November 2009, Hannover, Germany - 21-25 November, 2009
AAPS (American Association of Pharmaceutical Scientists) 2009 Annual Meeting - Posters: "Oral Irinotecan sustained release nanoparticles: formulation optimization and in vitro release profile"; "Tolerance and anti-tumoral efficacy of oral Irinotecan Sustained Release nanoparticles formulation in HT29 xenograft mice model"; "Pharmacokinetic profile of an Irinotecan Sustained Release nanoparticles formulation"
09 November 2009, Los Angeles, US - November 9-12, 2009
09 November 2009, Los Angeles, US - November 9-12, 2009
BIO-Europe 2009
02 November 2009, Vienna, Austria - November 2-4, 2009
02 November 2009, Vienna, Austria - November 2-4, 2009
BioPartnering Europe
11 October 2009, London, United-Kingdom - October 11-14, 2009
11 October 2009, London, United-Kingdom - October 11-14, 2009
Midcap Event
21 September 2009, Paris, France, 21 - 22 September
21 September 2009, Paris, France, 21 - 22 September
Presentation of 2009 half-year consolidated results
27 August 2009, Conference call in English at 11.30 am
27 August 2009, Conference call in English at 11.30 am
36th Annual Meeting and Exposition of the Controlled Release Society - Poster: " Optimization and in vivo evaluation of an oral Irinotecan-loaded Sustained Release Nanoparticles formulation"
18 July 2009, July 18 - 22, 2009 - Bella Center, Copenhagen, Denmark
18 July 2009, July 18 - 22, 2009 - Bella Center, Copenhagen, Denmark
Euro-BioTech Forum
29 June 2009, June 29 - July 1st, 2009 - Hotel Arts Barcelona, Spain
29 June 2009, June 29 - July 1st, 2009 - Hotel Arts Barcelona, Spain
XVIII International HIV Drug Resistance Workshop - Oral communication and poster: "New integrase binding inhibitors acting in synergy with Raltegravir"
12 June 2009, June 8-12, 2009 - Fort Myers, Florida, USA
12 June 2009, June 8-12, 2009 - Fort Myers, Florida, USA
2nd Pharmaceutical Sciences Fair and Exhibition, PharmSciFair - Oral communication: "Sustained Release Nanoparticles (SRN) for oral administration of Irinotecan"
10 June 2009, June 8-12, 2009 - Nice, France
10 June 2009, June 8-12, 2009 - Nice, France
BioEquity Europe
09 June 2009, Hilton Munick Park Hotel, Munich, Allemagne
09 June 2009, Hilton Munick Park Hotel, Munich, Allemagne
The 2009 American Society of Clinical Oncology (ASCO) Annual Meeting - Abstract: "Prevalence and management of oropharyngeal candidiasis (OPC) by medical and radiation oncologists in cancer patients"
29 May 2009, May 29 - June 2, 2009 - Orlando, Florida, USA
29 May 2009, May 29 - June 2, 2009 - Orlando, Florida, USA
American Society of Gene Therapy (ASGT) 12th Annual Meeting - Presentation of a poster: "Complete Melanoma Regressions after Electrotransfer of the p-AMEP(TM) Plasmid Coding for an Anti-Angiogenic and Anti-Metastatic Peptide"
28 May 2009, May 27-30, 2009 - San Diego, California, USA
28 May 2009, May 27-30, 2009 - San Diego, California, USA
2009 BIO International Convention
18 May 2009, Atlanta, Georgia - USA - May 18-21,2009
18 May 2009, Atlanta, Georgia - USA - May 18-21,2009
The American Conference for the Treatment of HIV (ACTHIV) - Presentation of a poster: "Once-Daily Miconazole Mucoadhesive Buccal Tablet is an Effective and Safe Treatment for Oropharyngeal Candidiasis"
15 May 2009, May 15-17, 2009, Denver, Colorado
15 May 2009, May 15-17, 2009, Denver, Colorado
Annual General Meeting
29 April 2009, Company's head office, Paris, France
29 April 2009, Company's head office, Paris, France
SmallCap Event
27 April 2009, Paris, France, 27 - 28 April
27 April 2009, Paris, France, 27 - 28 April
BioCapital Europe 2009
21 April 2009, Amsterdam, The Netherlands
21 April 2009, Amsterdam, The Netherlands
AACR 100th Annual Meeting 2009 (American Association for Cancer Research) Presentation of two abstracts: p-AMEP(TM), an anti-angiogenic and anti-invasive biotherapy for Metastatic Melanoma treatment; Oral Irinotecan Nanoparticles for the treatment of advanced colorectal cancer
18 April 2009, April 18-22, 2009 - Colorado Convention Center, Denver, Colorado
18 April 2009, April 18-22, 2009 - Colorado Convention Center, Denver, Colorado
BIO-Europe Spring 2009
16 March 2009, Milano Convention Center (MIC) Milano, Italy - March 16-18, 2009
16 March 2009, Milano Convention Center (MIC) Milano, Italy - March 16-18, 2009
16th Conference on Retroviruses and Opportunistic Infections: Presentation of a poster on a new quinoleine family of HIV integrase inhibitors
08 February 2009, Montreal, Canada - February 8-11, 2009
08 February 2009, Montreal, Canada - February 8-11, 2009
27th J.P. Morgan Healthcare Conference
12 January 2009, San Francisco, Cal, USA - January 12-15, 2009
12 January 2009, San Francisco, Cal, USA - January 12-15, 2009
Presentation of an abstract on p-AMEP(TM), a biotherapy for metastatic melanoma
15 December 2008, Journées Scientifiques du Cancéropôle Ile-de-France (15 - 17 December, 2008), Cité Universitaire Internationale, Paris, France
15 December 2008, Journées Scientifiques du Cancéropôle Ile-de-France (15 - 17 December, 2008), Cité Universitaire Internationale, Paris, France
Arkeon Finance small & midcap forum
18 November 2008, Paris, France
18 November 2008, Paris, France
Bio Europe
17 November 2008, Mannheim/Heidelberg, Germany - 17-19 November
17 November 2008, Mannheim/Heidelberg, Germany - 17-19 November
BioPartnering Europe
12 October 2008, London, UK - 12-14 October
12 October 2008, London, UK - 12-14 October
EuroBio
07 October 2008, Paris, France - 7-9 October
07 October 2008, Paris, France - 7-9 October
MidCap Event
29 September 2008, Paris, France
29 September 2008, Paris, France
ESMO - European Society of Medical Oncology
12 September 2008, Stockholm, Sweden - 12-16 September
12 September 2008, Stockholm, Sweden - 12-16 September